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ABSTRACT 
Treatment of rats  with 0.5-25  /zmol/100 g body weight of colchicine for 1 h  or 
more  caused  an  inhibition  of  hepatic  protein  synthesis.  This  effect  was  not 
seen  if the  animals  were  exposed  to  colchicine  for less  than  1  h.  The  delayed 
inhibition  of  protein  synthesis  affected  both  secretory  and  nonsecretory 
proteins.  Treatment  with  colchicine  (15  /zmol/100  g)  for  I  h  or  more  caused 
the  RNA  content  of  membrane-bound  polysomes  to  fall  but  did  not  change 
the  polysomal profile  of this  fraction.  By  contrast,  the  total  RNA  content  in 
the  free  polysome  cell  fraction  was  increased,  and  this  was  due  to  the 
presence  of  more  ribosomal  monomers  and  dimers.  Electron  microscope 
examination  of the  livers  from  rats  treated  for  3  h  with  colchicine  showed  an 
accumulation  of  secretory  vesicles  within  the  hepatocytes  and  a  general 
distension  of  the  endoplasmic  reticulum.  Administration  of  radioactive  L- 
leucine  to  the  rats  led  to  an  incorporation  of radioactivity  into  two  forms  of 
intracellular  albumin  which  were  precipitable  with  antiserum  to  rat  serum 
albumin  but  which  were  separable  by  diethylaminoethyl-cellulose  chroma- 
tography.  One  form  has  arginine  at  the  amino-terminal  position  and  is 
proalbumin,  and  the  other  form,  which  more  closely  resembles  serum 
albumin  chromatographically,  has  glutamic  acid  at  its  amino  terminus.  Only 
proalbumin  was  found  in  rough  and  smooth  endoplasmic  reticulum  fractions 
and  in  a  Golgi  cell  fraction  which  corresponds  morphologically  to  mostly 
empty  and  partially  filled  secretory  vesicles.  However,  in  other  Golgi  cell 
fractions  which  were  filled  with  secretory  products,  both  radioactive  proM- 
bumin  and  serum  albumin  were  found.  This  indicates  that  proalbumin  is 
converted  to  serum  albumin  in  these  secretory vesicles  just  before  exocytosis. 
Colchicine  delayed  the  discharge  of  radioactive  albumin  from  these  filled 
secretory  vesicles  and  caused  an  accumulation  of both  proalbumin  and  serum 
albumin within these cell fractions. 
KEY  WORDS  albumin  proalbumin  The  effects  of  colchicine  on  the  physiology  of 
secretion  Golgi  ￿9  colchicine  the  liver  and  on  the  secretion  of  plasma  pro- 
400  J. CELL  BIOLOGY ￿9 The Rockefeller University Press ￿9  0021-9525/78/0501-040051.00 teins  have  been  studied  in  detail  in  several 
laboratories.  These  studies  have  been  per- 
formed  in  perfused  liver,  in  liver  slices,  and  in 
the  intact  animals.  In the  perfused  liver,  10  /zM 
colchicine  does  not  affect  a  number  of  cellular 
parameters  such  as  oxygen  consumption,  glu- 
cose  production,  intracellular  adenosine  tri- 
phosphate  (ATP)  levels,  lipid  synthesis,  protein 
synthesis,  or  ureogenesis,  but  does  inhibit  the 
secretion  of  very  low  density  lipoproteins 
(VLDL) and plasma proteins (15). 
In  rat  liver  slices,  pulse-chased  with  radioac- 
tive  L-leucine,  colchicine  (10-6-10  5 M)  inhibits 
plasma  protein  secretion,  causes  a  concomitant 
retention  of  radioactive  nonsecreted  plasma 
protein  within  the  slices,  and  does  not  affect 
protein  synthesis  for  the  first  50  min  of incuba- 
tion (22). 
In  the  intact  rat  pretreated  for  3  h  with 
colchicine,  VLDL  release  is  inhibited,  and 
when given twice (0.25  /zmol/100 g body weight) 
at 0  min and 90 min for 150  rain, colchicine does 
not  affect  protein  synthesis,  although  higher 
doses  (10-fold)  have  a  slight  inhibitory  effect 
(27).  In  a  further  study,  in  which  it  was  shown 
that  colchicine  inhibits  lipoprotein  secretion 
but  does  not  interfere  with  the  secretion  of 
biliary  phospholipids  or  of  cholesterol,  1.25 
/zmol/100  g  of  this  drug  did  not  affect  the 
incorporation  of L-[aH]leucine  into  the total  pro- 
teins  of  the  liver and  serum  combined  (28).  At 
higher  concentrations  of  colchicine  (25  ~mol/ 
100  g  body  weight)  but  for shorter  time periods 
of  exposure  to  the  drug,  colchicine  inhibits 
secretion  of  plasma  proteins,  causes  an  accu- 
mulation  of  these  nonsecreted  proteins  in 
Golgi-derived  secretory  vesicles,  but  does  not 
impede  the  intracellular  movement  of  the  se- 
cretory  proteins  within  the  rough  or  smooth 
endoplasmic reticulum (1,22). 
There  are  conditions,  however,  under  which 
colchicine  affects  both  hepatic  protein  synthesis 
and  secretion.  For  example,  Dorling  et  al.  (5) 
have reported that  colchicine (0.625  /zmol/100 g 
body  weight)  causes  a  decreased  rate  of appear- 
ance  of  radioactive  albumin  in  the  blood  start- 
ing  60  min  after  administration  of the  drug  and 
that  this  effect persists  for  16  h.  It  was  further 
shown  by  these  investigators  that  2  h  after 
treatment  with  colchicine,  there  is  an  accumu- 
lation  of  L-['4C]leucine-labeled  albumin  in  the 
liver,  but  that  there  is  no  measurable  increase 
in  total  intracellular  albumin  content,  and  it 
was  concluded  that  the  failure  to  accumulate 
any  large  amounts  of proalbumin  or of albumin 
in  the  liver is due  to  an  inhibition  by  colchicine 
of  the  synthesis  of  proalbumin  and  its  subse- 
quent conversion to albumin. 
This  delayed  inhibitory  effect of colchicine on 
protein  synthesis  may  be  a  consequence  of  a 
primary  effect  of  this  drug  in  impeding  secre- 
tion,  which  may,  in  turn,  activate  feedback 
mechanisms  aimed  at  slowing  down  the  further 
synthesis  of  secretory  proteins.  On  the  other 
hand,  it may be  a  more  general effect caused  by 
affecting  the  cell's  metabolism.  To  distinguish 
between  these  and  other  possibilities,  and  to 
further  elucidate  the  process  by  which  colchi- 
cine  inhibits  hepatic  secretion,  we  have  studied 
in  detail  the  effects of colchicine on  the  synthe- 
sis  of  hepatic  proteins  and  on  the  secretion  of 
rat  serum  albumin,  with  emphasis  on  the  effect 
of this  drug  on  the  synthesis  of  serum  albumin 
and  on  the  intracellular  processing  of  proalbu- 
min to albumin. 
MATERIALS  AND  METHODS 
Animals 
Male rats  (90-190  g) were starved overnight before 
being  used.  In  those  experiments  in  which  Golgi cell 
fractions were isolated, the rats were fed alcohol (0.6 g 
ethanol  as  a  50%  solution/100  g  body  weight)  by 
stomach  tube  1  h  before  the  administration  of 
colchicine  or  radioactive  L-leucine.  Injections  of 
colchicine  or  of  radioactive  amino  acids  were  per- 
formed  with  the  rats  under  light  ether  anesthesia 
and were administered via the femoral vein. Control rats 
received equal volumes of saline instead of colchicine. 
Cell Fractionation  Procedures 
Rough and  smooth endoplasmic reticulum cell frac- 
tions were prepared as described by Dallner and Emster, 
(4) and Golgi cell fractions (22) and free and membrane- 
bound  polysomes  (23)  were  prepared  by  previously 
described procedures. 
Isolation of Proteins 
Radioactivity in serum proteins, albumin, and ferritin 
was  determined  as previously described (23,  24) using 
rabbit antiserum  to rat serum proteins, to rat albumin, 
or to horse ferritin, which cross-reacts  with rat ferritin. 
The cell fractions, usually  from 5 to 8 g of liver, were 
treated with 0.5% sodium deoxychotate and centrifuged 
at  150,000g  for  1 h  before  treatment  with antibodies 
(22). When total hepatic albumin was isolated, the livers 
were homogenized in 5 vol of 0.01  M Tris-HCl, pH 7.4 
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late and centrifuged at 150,000g  for 1 h. The albumins 
in the supernatant fraction were then obtained by im- 
munoprecipitation with  rabbit  antiserum  to  rat  serum 
albumin. 
Proalbumin and hepatic albumin were obtained from 
the albumin immunoprecipitate by a modification of the 
method  described  by  Judah  and  Nicholls  (13).  The 
immunoprecipitates, washed with  saline, were treated 
with cold 5%  trichloroacetic acid  (TCA), placed in ice 
for 30 min, and then centrifuged. The TCA precipitates 
were washed three  times with cold 5%  TCA  and ex- 
tracted three times for 1 h each time at 4~  with 5 ml of 
1% TCA in 95% ethanol. The pooled ethanolic extracts 
were dialyzed overnight at 4~  against  0.1  M Tris-HC1, 
pH 7.8. The dialyzed material was centrifuged to remove 
any insoluble  protein and chromatographed on a 1 ￿  50 
cm DEAE-cellulose column (Whatman DE 52) at room 
temperature. The sample was applied after mixing with 
40  or  50  mg of rat  serum  albumin;  the column  was 
washed with 50 ml of 0.1  M Tris-HCl, pH 7.8; and the 
proteins were eluted with a  500-ml  linear gradient of 
0.1-0.3  M  Tris-HCi, pH  7.8.  Fractions of 3  ml were 
collected and assayed for radioactivity  and for absorb- 
ancy at 280 nm. 
Radioactive serum  albumin  was  obtained from the 
plasma of a rat 60 min after injection with L-[3H]leucine. 
The plasma was treated with 5% TCA and the precipi- 
tate  was washed three  times with cold 5%  TCA  and 
extracted with  1%  TCA  in  95%  ethanol as described 
above. After dialysis, this material was chromatographed 
on DEAE-ceilulose as described above. 
Other Procedures 
Amino-terminal analysis was performed by the man- 
ual Edman degradation method as modified by Iwanaga 
et  al.  (12).  The  intracellular  albumins  from six  rats, 
treated with 15  /~mol/100  g of colchicine, were labeled 
in  vivo  for 30  min with L-[G-3H]glutamic  acid  (30Ci/ 
mmol) and L-[U-14C]arginine (0.324 Ci/mmol), as proal- 
bumin is known to have N-terminal arginine (31,  20, 
26,)  and serum albumin contains N-terminal glutamic 
acid (3).  Each rat received 0.1  mCi of L-[3H]glutamic 
acid and 0.05  mCi of L-[14C]arginine. Proalbumin and 
hepatic albumin were then isolated from combined Golgi 
and ER cell fractions by immunoprecipitation, alcohol 
extraction, and DEAE-cellulose chromatography as de- 
scribed  above.  Serum  albumin,  labeled  with  L- 
[aH]glutamic acid and L-[~'C]arginine, was also prepared 
as described above but was obtained from the plasma of 
a single rat, 60 min after the administration of radioac- 
tive amino acids. 
Nonradioactive albumin, used as a marker in DEAE- 
cellulose  chromatography, was prepared from 50 ml of 
rat  serum. The  serum proteins were precipitated with 
5% cold TCA, washed three times with cold 5% TCA, 
and extracted five times with 35 ml of 1% TCA in 95% 
ethanol.  The  pooled ethanolic extracts were  dialyzed 
extensively at  5~  with  0.01  M  Tris-HCl,  pH  7.4  in 
0.154  M  NaCl.  When  this  material  was  chromato- 
graphed at  5"C  on  Sephadex G100,  it  eluted as one 
major peak which, on immunoelectrophoresis against  a 
multivalent rabbit antiserum to rat serum proteins, gave 
a  single  albumin precipitation band. The albumin  thus 
obtained was dialyzed against water and stored at -20~ 
as a lyophilized powder. 
Protein precipitates were dissolved in 1 ml of Soluene 
with 0.1 ml of glacial acetic acid. The samples were then 
counted with 10 ml of toluene scintillation  phosphor in a 
Packard scintillation  counter (Packard Instrument Co., 
Inc., Downers Grove, Ill.). Protein was assayed by the 
method of Lowry et al. (16) using bovine serum albumin 
as standard, and RNA was determined by the Orcinol 
method (17) using yeast RNA as standard. 
Electron Microscopy 
Liver samples were fixed in 2.5% formaldehyde, 2% 
glutaraldehyde in 0.1  M  cacodylate buffer, pH  7.2  at 
4~  for 1 h, and postfixed in  1%  osmium tetroxide at 
4~  for another hour. The specimens were dehydrated 
with  acetone  and  embedded  in  Epon  812  mixture. 
Sections  were  stained  with  uranyl  acetate  and  lead 
citrate. Electron micrographs were made with a Philips 
electron microscope, model 201. 
Sources of Materials 
Radioactive amino acids were purchased from Amer- 
sham-Searle Corp., Arlington Heights, Ill.;  DEAE-cel- 
lulose  (DE52)  from  Whatman,  Inc.,  Clifton,  N.  J.; 
colchicine  from Sigma  Chemical Co.,  St.  Louis, Mo.; 
and  Soluene  from  Packard  Instrument  Co.,  Inc.  Rat 
serum  albumin  was  prepared  by  us  from  rat  serum 
obtained from Pel-Freez Farms, Inc., Rogers, Ark. 
RESULTS 
General Effects of Colchicine on 
Hepatic Protein Synthesis 
Rats  were  treated  either with  25  /xmol/100  g 
body weight of colchicine or with saline. At var- 
ious time intervals, from immediately after injec- 
tion to 4 h after the administration of the drug, L- 
[U-~4C]leucine  was  given  intravenously  for  10 
min, the livers were removed, and the radioactiv- 
ity  incorporated  into  TCA-precipitable  proteins 
and  into  total  hepatic  albumin  was  determined. 
As  a  measure  of  the  uptake  of  radioactive  L- 
leucine  by  the  liver,  the  radioactivity  in  TCA- 
soluble fractions from the  liver homogenate was 
also determined. 
If L-[14C]leucine was given immediately after or 
15-30 min after colchicine, the drug was shown to 
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ity into TCA-precipitable protein or into hepatic 
albumin.  After  1  h  of colchicine  pretreatment, 
however,  there  was  a  decrease  in  the  levels of 
radioactivity in  both  TCA-precipitable proteins 
and  in  hepatic albumin,  and  this inhibition per- 
sisted  for  4  h  (Fig.  1).  In  some  experiments, 
longer  periods  of  colchicine  treatment  (6-8  h) 
were tested and resulted in similar effects. Keep- 
ing the animals for longer periods after colchicine 
pretreatment (25  p~mol/100 g), such as overnight 
periods,  frequently  resulted  in  the  death  of the 
rats. 
The  L-leucine radioactivity in the TCA-soluble 
fractions,  which  represents  mostly  intracellular 
free  L-leucine,  increased after  1  h  of colchicinc 
pretreatment  and  reached  a  maximal  level  at 
about 3 h after colchicine treatment (Fig. 2, top). 
Dorling  et  al.  have  shown  that  the  amino  acid 
pools  vary  after  colchicine  treatment,  with  the 
intracellular  specific  radioactivity  of  L-leucine 
being  raised  150%  but  that  of  glutamic  acid, 
glycine,  alanine,  lysine,  and  histidine being  de- 
creased (5). 
If L-[14C]leucine  was administered to rats pre- 
treated  for  3  h  with  colchicine,  then  a  peak 
intracellular  level  of  radioactive  L-leucine  was 
noticed within 2-3 min of L-[14C]leucine  adminis- 
tration. In saline-treated rats, the highest intracel- 
lular level of radioactive L-leucine was at  2  min 
after administration, and the "pulse" was sharper 
than in colchicine-treated rats, with lower intracel- 
lular levels of radioactive L-leucine at 3 min and at 
subsequent times up to 10 min after L-[14C]leucine 
administration (Fig. 2, bottom). 
To  determine  the  in  vivo doses of colchicine 
which cause this delayed inhibitory effect on pro- 
tein  synthesis, rats were  pretreated with various 
doses of colchicine for 3 h and the rats were then 
pulse-labeled with L- [  U-'4C]leucine for 10 min. At 
0.5  ~mol  of colchicine/100  g  body  weight,  the 
drug had a small inhibitory effect on the incorpo- 
ration of radioactivity into both TCA-precipitable 
proteins  and  albumin.  At  concentrations  of  5 
#mol/100 g body weight or at higher doses up to 
25  /~mol/100 g body weight, colchicine progres- 
sively inhibited incorporation into these proteins 
(Fig. 3). 
Effects of Colchicine on Free 
and Membrane-Attached Polysomes 
Although  albumin  and  other  plasma proteins 
are  synthesized  on  membrane-attached  poly- 
somes,  it is not  possible to  generalize that  only 
secretory  proteins  are  made  by  membrane-at- 
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FIGURE  1  Incorporation of  L-[WJ4C]leucine into  TCA-precipitable protein  and  into  albumin  after 
various  times of colchicine pretreatment. Rats were  injected intravenously  with 25  p.mol/100 g body 
weight of coichicine. At the indicated times 9  /zCi/100 g body weight of L-[U-'4C]leucine (324 mCi/ 
mmol) was given in the femoral vein, and the livers were removed after 10 min, rinsed with 0.154  M 
NaCI, blotted, and homogenized  in 0.154  M NaCI in 0.01  M Tris-HCl,  pH 7.4. The incorporation  of 
radioactivity  into  TCA-precipitable proteins  and  into  albumin  immunoprecipitate  was  determined 
as  described in  Materials and  Methods.  The  dotted  line  represents  the  incorporation into  TCA- 
precipitable protein and the solid line represents the incorporation  into albumin. 
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FIGURE 2  Intracellular  hepatic  levels  of  L-[U- 
t4C]leucine  in  control  and  colchicine-treated  rats. 
Top:  Rats were pretreated  with 25  /~mol/100 g body 
weight of colchicine and at the  times indicated were 
pulse-labeled for  10  min with L-[U-14C]leucine as  in 
Fig.  1. The  livers were removed, rinsed, and homog- 
enized in 0.154 M NaCI, 0.01 M Tris-HC1, pH 7.4. The 
homogenate was treated with cold 10% TCA and the 
radioactivity in  10%  TCA-soluble fraction was taken 
to be the  intracellular level of L-[U-14C]leucine.  Bot- 
tom:  Rats  were treated  with either  15  txmol/100 g 
body weight of colchicine or with saline 3 h before the 
intravenous injection of L-[U-~4C]leucine  as described 
in Fig. 4. At the times indicated after the administra- 
tion of radioactive L-leucine, the  livers were removed 
and homogenized in 0.25 M sucrose. The radioactivity 
in a  10%  TCA-soluble fraction from the homogenate 
was  taken  as  the  intracellular  level  of  L-[U- 
~4C]leucine. The  dotted  lines  represent  the  intracel- 
lular  levels of  L-[U-~4C]leucine in  colchicine-treated 
rats  and  the  solid lines  represent  that  in  saline- 
treated animals. 
tached polysomes and that nonexportable proteins 
are  made by free polysomes, inasmuch as it has 
been shown that some nonsecretory proteins are 
made on membrane-attached polysomes (21, 10). 
There is strong evidence, however, that secretory 
plasma  proteins are  finally assembled on mem- 
brane-attached polysomes (24,  30,  8,  9)  before 
their vectorial discharge into the cisternae of the 
rough endoplasmic reticulum (ER) (25), and that 
some nonexportable proteins, such as ferritin, are 
preferentially  synthesized,  although  not  exclu- 
sively,  by  free  polysomes  (9,  24,  14).  If  the 
delayed inhibitory action of colchicine on protein 
synthesis is a feedback mechanism brought about 
by the delay in secreting plasma proteins, it may 
be expected  that this drug will preferentially in- 
hibit protein by membrane-attached rather than 
free polysomes. To determine whether this is true, 
rats were pretreated for various times from 0.5 to 
3  h  with colchicine, and the  in vivo synthesis of 
proteins  by  both  free  and  membrane-attached 
polysomes was measured 2-10 min after L-[UJ4C]- 
leucine  administration.  Coichicine  had  no  ef- 
fect  on  protein  synthesis  or  on  either  free  or 
membrane-attached polysomes after 0.5 h of col- 
chicine pretreatment, but did inhibit both classes 
of polysomes after  1,  2,  and  3  h  of treatment. 
Colchicine inhibited the incorporation of radioac- 
tivity into TCA-precipitable proteins, in both free 
and  membrane-attached polysomes  at  all  times 
measured between 2 and 10 min after radioactive 
L-leucine administration. A representative experi- 
ment,  taken  at  3  h  after  colchicine treatment, 
when the effect is maximal is shown in Fig. 4. 
After  3  h  of  treatment  with  15  /xmol/100 g 
body weight of colchicine, it was noticed that the 
recovery of RNA in the free polysomal cell frac- 
tion increased from 0.77 mg RNA/g liver to 1.15 
mg/g liver, and that at the same time there was a 
decrease  in  the  RNA  content of membrane-at- 
tached polysomes from  1.31  to 0.54 mg RNA/g 
liver.  However,  as  shown  above,  colchicine  in- 
hibited protein synthesis in both classes  of poly- 
somes. To analyze further this degradative effect 
of  colchicine  on  the  membrane-attached  poly- 
somes, rats were treated with the drug for various 
periods of time, choosing those times (0 and 30 
rain) at which colchicine does not affect protein 
synthesis and other times (1  and 3  h) when the 
delayed effect of colchicine on protein synthesis is 
maximal. Free and membrane-attached polysomes 
were isolated from the liver, and both the amounts 
of RNA/g liver and the profiles of the two classes 
of polysomes were determined. At zero time and 
at 29 min after colchicine, when the drug has little 
or  no  effect  on  protein  synthesis,  the  RNA 
content of both free and membrane-attached poly- 
somes was unchanged. Also unchanged was the 
profile of the polysomes measured as the percent 
of ribosomes which appear as either monomers, 
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FmURE  3  Effect  of  pretreatment  with  various  concentrations  of  colchicine  on  the  synthesis  of 
albumin  and  TCA-precipitable  proteins.  Male  rats  (160-190  g)  were  administered  various amounts 
of colchicine, and  3 h  later 3  /.LCi/100 g body weight of L-[U-14C]leucine (324 mCi/mmol) was given. 
After  10  min of the  latter  injection, the  livers were  removed and  the  incorporation  of radioactivity 
into  TCAoprecipitable protein  and  albumin  was  determined  as  described  in  Fig.  1.  The  dotted  line 
represents the incorporation into TCA-precipitable protein and the solid line that into albumin. 
7" 
7 
o  ,v  ,  '  '  '  ~  :I 
~ 4  ~(~X  3  -  ATTACHF:D  L 
2 
1  //  "~--,  I-  -e 
i  i  i  l  l  ￿9  i 
I  2  3  4  5  I0 
MINUTES 
FIGURE 4  Time-course  of  incorporation  of  L-[U- 
~C]ieucine  into  nascent  proteins  of  free  and  mem- 
brane-attached  polysomes.  Some  rats  (115-130  g) 
were  pretreated  with  15  /xmol/100 g  body  weight  of 
colchicine for  3  h  while others  received saline.  L-[U- 
~C]leucine (8 tzCi/100 g, 324 mCi/mmol) was injected 
intravenously, and the livers were removed at 2,  3,  5, 
and  10  min  after  L-[t~C]leucine  administration.  After 
cell  fractionation  into  free  and  membrane-attached 
polysomes,  the  radioactive  incorporation  into  TCA- 
precipitable  proteins  was  determined.  The  solid  lines 
dimers, or larger than dimers. 
However,  after  1  and  3  h  of colchicine treat- 
ment,  the  amount  of  RNA/g  liver  in  the  free 
polysomes went up from  0.77  mg/g liver at zero 
time to  1.11  mg/g liver at 1 h and  1.15 mg/g liver 
at  3  h.  At  the  same  time,  the  profile  of  these 
polysomes exhibited a  large increase in the num- 
ber of monomeric and  dimeric ribosomes  (Table 
I).  By  contrast,  the  membrane-attached  poly- 
somes  showed  a  decrease  in  RNA  content  at  1 
and  3  h  after colchicine treatment  (1.31  mg/g to 
0.6  and  0.54  mg/g)  but  showed  no  change  in 
polysomal profile as evidenced by the fact that the 
percent  of monomeric  or  dimeric  ribosomes  re- 
mained relatively unchanged  (Table  I). 
It appears  that  degranulation  of the rough  ER 
occurs after lengthy colchicine treatment, and that 
some  of the  ribosomes  which  are  released  from 
the rough ER may appear as monomers or dimers 
together  with  the  free  polysomal  cell  fraction. 
Because  more  RNA is lost from  the membrane- 
attached  polysomes than  is recovered in the free 
polysomal  fractions  (Table  I),  it  is  possible  that 
the other ribosomes released from the membranes 
may remain undetected  in the cytoplasm as ribo- 
somal subunits,  or may become degraded. 
indicate  the  control  and  the  dotted  lines indicate  the 
colchicine-treated rats. 
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Polysomal Profile of Free and Membrane-Attached Polysomes of Colchicine-Treated Rats 
Free  Membrane-attached 
Time after 
colchicine  RNA  Monomers  Dimers  >2  RNA  Monomers  Dimers  >2 
train)  (mg/g)  (%)  ~mg/g)  (%) 
0  0.77  5.6  8.9  85.5  1.31  9.8  12.8  77.4 
29  0.79  4.6  6.1  89.3  1.11  11.0  10.4  78.6 
60  1.11  9.1  18.0  72.9  0.60  8.2  7.5  84.3 
180  1.15  9.7  18.0  72.3  0.54  11.4  11.0  77.0 
Rats (180-190 g) were injected with 15 tzmol/100  g body weight of colchicine  and at the times indicated the livers 
were removed and fractionated into free and membrane-attached polysomes. The polysomes were resuspended in 
water, and aliquots were taken for RNA analysis.  Polysomes corresponding to -50 OD20o units were then layered 
on a 10-40% sucrose gradient containing 0.01 M Tris-HCl, pH 7.4, mM MgCI2, and 25 mM KCI, and centrifuged 
for 105 min at 25,000 rpm in a Beckman SW27 rotor. The samples were collected by flotation (3 ml/min), and the 
optical density profile at 260 nm was recorded on a chart (3 min/ml). The polysomal profiles thus obtained were 
traced on 100% rag paper, and the areas on the tracings  which corresponded to ribosomal monomers, dimers, and 
forms larger than  dimers were  cut out and  weighed.  The data  presented  are  given as  the  percent of the  total 
polysomal profile which  appears as either ribosomal monomers, dimers, or as aggregates larger than dimers. The 
amount of polysomal RNA recovered per gram liver is also shown and  is the average value obtained from two 
separate  experiments with two animals at each time-point. The polysomal profile was  only taken  in the second 
experiment, and the values given arc the averages from two separate rats. 
Effect on Synthesis of Specific 
Hepatic Proteins 
To  determine  whether  pretreatment  with  col- 
chicine affects the synthesis of all hepatic protein 
or more  specifically inhibits only the synthesis of 
secretory  proteins,  rats  were  treated  with colchi- 
cine  for  3  h  and  the  incorporation  of L-[U-~4C] - 
leucine into different hepatic protein fractions was 
examined.  Inhibition of radioactive incorporation 
by colchicine was seen in the total TCA-precipita- 
ble proteins  obtained  from the  liver homogenate 
and  in  protein  obtained  from  the  deoxycholate- 
soluble endoplasmic reticulum, which represents a 
mixture of ER membrane proteins and any other 
proteins,  mostly  secretory  ones,  which  are  se- 
questered  within  the  cisternae  of the  ER  (Table 
II). An equal level of inhibition by colchicine was 
also seen both in the nascent plasma proteins con- 
tained within the ER and in the proteins residing 
in  the  soluble  cell-fraction. The  soluble  cell frac- 
tion  contains  not  only  soluble  nonsecretory  pro- 
tein,  but  may  also  contain  secretory  proteins 
which  may  have  been  released  into  this  fraction 
during homogenization due to the rupture  of ER 
and  Golgi  vesicles.  To  eliminate  the  secretory 
proteins  from  this  fraction,  the  soluble  cell frac- 
tion  was  treated  with  a  multivalent  rabbit  anti- 
serum to rat plasma,  and the resulting supernate, 
containing  mostly  soluble  nonsecretory  proteins, 
was assayed for radioactivity. The results demon- 
strate that the synthesis of these soluble nonsecre- 
tory  proteins  was  also  inhibited  by  pretreatment 
with colchicine.  Further  evidence  that  colchicine 
inhibits the synthesis of nonsecretory proteins was 
obtained by showing that the synthesis of a specific 
nonsecretory protein, ferritin, was also depressed 
by  colchicine  (Table  II).  This experiment  shows 
that  pretreatment  of rats  with colchicine inhibits 
incorporation  of radioactive  L-leucine  into  most 
hepatic proteins  and that the effect is not limited 
to  secretory  proteins.  Taken  together  with  the 
previous experiments  which indicate  that  the de- 
layed  effect  of  colchicine  on  protein  synthesis 
affects  both  free  and  membrane-attached  poly- 
somes,  these  results  suggest  that  the  effect  of 
colchicine  on  protein  synthesis  is  a  general  one 
which  affects  all  or  most  hepatic  proteins,  and 
that it is not a specific feedback mechanism affect- 
ing only secretory proteins. 
Conversion of Proalbumin to 
Hepatic Albumin 
Within  the  hepatocyte,  albumin  exists  in  a 
precursor  form,  termed  proalbumin,  and  is con- 
verted  into  serum  albumin  before  secretion  into 
the blood. Rat proalbumin has been characterized 
as containing a  hexapeptide  extension  (Arg-Gly- 
Val-Phe-Arg-Arg)  at  the  N-terminus  of  serum 
albumin  (31,  20,  26).  Recently,  Ikehara  et  al. 
(11)  have  shown  that  proalbumin  in  vivo,  is 
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Effect of 3 h of Colchicine  Pretreatment  on the 
Synthesis  of Secretory  and Nonsecretory  Protein 
L-lU~4C]leucine incorporation  in proteins 
% Inhibi- 
Control  Colchicine  tion 
(cpm/mg cell fraction protein) 
Homogenate  3,901  2,065  47 
DOC-soluble ER  15,037  6,917  54 
ER, plasma proteins  2,946  1,290  56 
Soluble cell fraction  1,803  1,020  43 
Soluble nonsecretory  1,546  843  46 
proteins 
Ferritin  36  18  50 
Rats  (90-100  g)  were pretreated  for  3 h  with 15 
/xmol/100 g body weight of colchicine and then  14.75 
/xCi/100 g of  L-[U-14C]leucine (324  mCi/mmol)  was 
injected  intravenously. After  20  min, the  livers were 
removed  and  fractionated  into  various cell fractions. 
Radioactivity was determined in the TCA-precipitable 
proteins  of  the  homogenate,  endoplasmic  reticulum 
(ER).  and soluble fractions. Also determined were the 
radioactivities in nascent plasma proteins and in ferritin 
(see Materials and Methods). The radioactivity in solu- 
ble nonsecretory proteins was determined by treating the 
soluble cell fraction with antiserum to plasma proteins, 
to remove any secretory protein present in this fraction, 
and then by precipitating the remaining soluble fraction 
with 5% TCA, The incorporation of radioactivity into 
the various protein fractions is expressed as radioactivity 
per milligram of protein of the cell fraction from which 
the proteins were obtained. 
Control  rats  received saline  instead of colchicine. 
Each value is the average of four separate determina- 
tions using different rats for each determination. 
converted into serum albumin while it is contained 
within Golgi-derived secretory vesicles, and stud- 
ies  by  Edwards  et  al.  show  that  in  liver  cell 
suspensions the  conversion of proalbumin to se- 
rum albumin occurs in both the smooth ER and in 
the Golgi apparatus (6). 
Because the conversion of proalbumin to albu- 
min in vivo occurs in the Golgi cell fraction, and 
because this is the cellular site at which colchicine 
blocks  secretion,  we  investigated  in  detail  the 
effect of this drug on the processing of proalbumin 
to  serum  albumin,  paying  special  attention  to 
events which occur in the various Golgi fractions. 
Rats  were  fed  alcohol,  as  this  procedure  has 
been shown to increase the yield of the Golgi cell 
fraction and because the  isolated Golgi fractions 
obtained by this method have been well character- 
ized (7, 22). L-[aH]leucine  was then administered 
to saline as well as to colchicine-treated rats, and 
the livers were removed at various times, from 18 
to  75  min,  after  L-[3H]leucine  administration. 
After  cell fractionation into rough  ER,  smooth 
ER,  and  Golgi  fractions  l,  2,  and  3,  nascent 
albumin was isolated from these cell fractions by 
immunoprecipitation with rabbit antiserum to rat 
albumin, and was separated into proalbumin and 
serum albumin by DEAE-cellulose chromatogra- 
phy. Also measured .was the incorporation of ra- 
dioactivity into albumin which had been secreted 
into the blood. This latter albumin fraction was 
also  subjected to  DEAE-cellulose chromatogra- 
phy. 
In the rough and smooth ER cell fractions and 
in Golgi fraction 3, the only radioactive product 
in the antialbumin  immunoprecipitate  appeared to 
be proalbumin, as it elutes before serum albumin 
on DEAE-cellulose chromatography (13) and, as 
shown  later,  it  contains N-terminal arginine in- 
stead  of  the  N-terminal glutamic acid  normally 
seen  in  serum  albumin. There  was  little  or  no 
protein radioactivity which  eluted together  with 
rat serum albumin in these cell fractions (Fig. 5). 
By contrast, in Golgi fractions 2 and 1, there were 
two  radioactive  proteins obtained after  DEAE- 
cellulose  chromatography.  The  first  radioactive 
protein,  which  is  proalbumin, was  eluted  as  a 
sharp peak before the elution of serum albumin. 
The  second  radioactive  protein,  which  is  more 
acidic,  was  eluted  as  a  broader  band,  and  its 
elution profile was  close  to  but not identical to 
that of added rat serum albumin. The radioactive 
albumin obtained from  plasma,  in marked con- 
trast to that from the various cell fractions, showed 
only one radioactive product which appeared  in 
the  more  acidic  position,  and  the  radioactivity 
closely followed that of added rat serum albumin. 
There was no indication of a proalbumin radioac- 
tive peak in the plasma samples (Fig. 5). 
Golgi fraction 3 has been previously shown to 
consist of flattened Golgi cisternae with distended 
rims which occasionally show some VLDL parti- 
cles,  and  Golgi  fractions  2  and  1  consist  of 
rounded secretion vacuoles filled with VLDL par- 
ticles and an amorphous dense matrix (22). These 
experiments, therefore,  suggest that  proalbumin 
exists  throughout most  of the  secretory  process 
but that,  as the  Golgi-derived secretory vesicles 
are filled (Golgi fractions 1 and 2), proalbumin is 
converted to another form of albumin. 
Because the  second radioactive peak obtained 
from  Golgi  fractions  1  and  2  does  not  elute 
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FIGURE  5  Radioactivity  in  proalbumin  and  albumin  obtained  from  various  liver cell  fractions and 
from plasma. Rats were injected with 25  /~mol/100 g body weight of colchicine. This was immediately 
followed by the  administration of 250  /zCi/100 g  of L-[4,5-3H]leucine  (50  Ci/mmol).  In the  cases in 
which  rough  and  smooth  endoplasmic  reticulum  cell  fractions  were  obtained,  the  livers  were 
removed  20  min  after  L-[aH]leucine  injection.  The  rats  from  which  Golgi  fractions were  obtained 
were  fed alcohol (0.6  g/100 g  body weight)  1  h  before  the  administration of drugs.  The livers were 
removed after 30  min.  The  plasma was obtained from rats which had been treated with radioactive 
L-leucine  for  1  h.  The  detergent-treated  cell  fractions  were  immunoprecipitated  with  antialbumin, 
and  the  radioactive proteins thus obtained were  then chromatographed on  DEAE-cellulose  together 
with 50 mg of added serum albumin, as described in Materials and Methods. The figures above only 
show  some  of  the  eluted  fractions as  the  earlier  fractions  do  not  contain  protein  or  radioactivity. 
Each  fraction  (3  ml)  was  assayed  for  radioactivity  and  for  absorbance  at  280  nm.  Each  figure 
represents  a  different  but  representative  experiment  using  separate  animals.  The  dotted  lines  show 
the absorbance at 280  nm of added  serum  albumin and the solid lines show the radioactivity. RER, 
rough  endoplasmic reticulum; SER,  smooth endoplasmic reticulum;  and  G1,  G2,  and  G3  are  three 
different Golgi fractions (described in the text). 
after  DEAE-cellulose  chromatography  by  deter- 
mining  N-terminal  residues.  It  is  known  that 
proalbumin  contains  arginine  in  its  N-terminus 
(31, 20, 26) and serum albumin contains glutamic 
acid (3). Because it is difficult to obtain sufficient 
amounts  of  these  proteins  from  the  various  cell 
identically with added rat serum albumin, and the 
radioactive  albumin obtained  from  plasma  does, 
this may indicate that the albumin obtained from 
these  cell  fractions  may  be  chemically  different 
from serum  albumin￿9 We  therefore attempted to 
further identify the radioactive  proteins obtained 
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acid  by  conventional  analysis,  L-[U-~4C]arginine 
and L-[G-3H]glutamic acid were injected into col- 
chicine-treated rats, and after 30 min the intracel- 
lular  radioactive  albumins  were  isolated  from 
combined Golgi and  ER cell fractions by immu- 
noprecipitation and were separated into proalbu- 
min and hepatic serum albumin by DEAE-cellu- 
lose chromatography. A  manual Edman degrada- 
tion  N-terminal  analysis was  performed  on  the 
separated proteins (12), but was modified so that 
identification  was  performed  by  determining 
whether 14C or 3H was contained in the cleaved N- 
terminal amino acid residue. The first radioactive 
peak  (proalbumin)  obtained  from  DEAE-cellu- 
lose chromatography showed an N-terminal argi- 
nine, in that the radioactive amino acid obtained 
on  the first Edman degradation contained 5,600 
dpm of ~4C-radioactivity which was about 4%  of 
the total 14C-radioactivity in the proalbumin frac- 
tion.  This  same  protein  fraction  contained 
100,800 dpm of L-[3H]glutamic acid radioactivity, 
but only 90 dpm of 3H was released on the first 
Edman degradation step. The second peak, which 
eluted  close  to,  but  not  identical  with,  serum 
albumin showed N-terminal glutamic acid, in that 
about  1%  (258 dpm) of the 3H-radioactivity was 
released  by  this  procedure,  but  no  significant 
[14C]arginine  was seen in the N-terminal position. 
An N-terminal  analysis, using  the  above  proce- 
dures on  radioactive albumin obtained from  the 
plasma,  60  min  after  the  administration  of  L- 
[~4C]arginine  and  L-[3H]glutamic  acid,  showed 
that the secreted albumin also contained only N- 
terminal glutamic acid. Thus, the second radioac- 
tive protein obtained from the liver appears to be 
similar to secreted albumin with respect to its N- 
terminal composition, and the reason for its slight 
chromatographic difference is not known. 
These experiments indicate that the conversion 
of proalbumin to albumin occurs in filled Golgi- 
derived secretory vesicles (Fig.  5),  which  is the 
same  cellular site  at  which  colchicine causes  an 
accumulation of nascent albumin (22). To deter- 
mine whether colchicine affects the conversion of 
proalbumin to albumin, we followed, with time, 
the  appearance  of  radioactive  proalbumin  and 
hepatic serum albumin in the 3 Golgi cell fractions 
and  in  the  plasma  obtained  from  control  and 
colchicine-treated rats. 
In Golgi fraction 3, which corresponds to mostly 
empty or only partially filled Golgi vesicles, radio- 
active proalbumin appears within  18  min of the 
administration  of  radioactive  L-leucine.  At  this 
time and at 30 min, colchicine has little effect on 
the  amount  of radioactive proalbumin recovered 
from this cell fraction (Fig. 6). At later times, 45- 
75  min,  there  is  a  decline  in  the  amount  of 
radioactive proalbumin seen in this cell fraction, 
as  presumably  this  protein  passes  to  the  other 
more filled secretory vesicles represented by Golgi 
fractions 2 and 1. At these later time intervals, 45 
min and later, a small amount of residual hepatic 
serum albumin begins to appear in Golgi fraction 
3,  but  it  should  be  noted  that  at  these  time 
intervals there has already been substantial secre- 
tion of albumin out of the cell and into the plasma 
(Figs. 6 and 7). 
In Golgi fractions 1 and 2, radioactive proalbu- 
min  also  appears  within  18  min  and  reaches  a 
peak  concentration  at  about  30  min.  At  later 
times,  the  amount  of radioactive proalbumin  in 
these cell fractions declines, and they are almost 
emptied within 60 min.  At about the same time 
that  proalbumin appears, radioactive hepatic se- 
rum  albumin also is seen  in these cell fractions, 
and  this protein also appears to decline after 30 
min and is mostly discharged by 1 h. It is difficult 
to  see  a  precursor product  relationship in  these 
studies, but, clearly, as the radioactive proalbumin 
and hepatic albumin decline in Golgi fractions 1 
and  2  (Fig. 6),  the  serum albumin secreted into 
the plasma increases (Fig. 7) and there appears to 
be  no  proalbumin  in  the  plasma  even  at  the 
earliest time interval measured. 
Colchicine  appears to  have  little effect in the 
first 18 min on the level of proalbumin or hepatic 
serum  albumin  in  these  Golgi cell fractions,  al- 
though there was always slightly more radioactive 
protein in  the  Golgi cell fractions of colchicine- 
treated animals. Colchicine, however, appears to 
delay  the  discharge  of proalbumin  and  hepatic 
serum albumin from these fractions. With increas- 
ing time, the radioactivity in both proalbumin and 
hepatic albumin is higher in the secretory vesicles 
of  colchicine-treated  rats  because  the  levels  of 
these  radioactive proteins in  the control animals 
has dropped with time as the albumin is secreted 
into the plasma, while the levels in the colchicine- 
treated rats have remained high. This is particu- 
larly noticeable in Golgi fraction 1 (Fig. 6).  Col- 
chicine does not specifically cause the accumula- 
tion of only one form of albumin. 
Morphology 
Treatment for 3 h with colchicine (25 p~mol/100 
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FmURE  6  Time-course  of  appearance  of  nascent  proalbumin  and  intracellular  serum  albumin  in 
Golgi fractions of control and colchicine-treated rats.  Rats were fed 0.6 g/100 g body weight of alcohol 
1  h  before  the  administration  of  colchicine  and  L-[4,5-aH]ieucine.  Colchicine  (or  saline)  was  given 
intravenously,  and  this  was  immediately  followed  by  the  administration  of  250  /xCi/100  g  of 
L-[4,5-aH]leucine  (50 Ci/mmol). The livers were removed at the indicated  times after the injection of 
L-[aH]leucine,  and  Golgi fractions were  prepared.  Proalbumin  (column  A)  and  intracellular  albumin 
(column  B)  were  separated  by  DEAE-cellulose  chromatography  as  described  in  Fig.  5.  The 
radioactivities  in  proalbumin  and  albumin  were  obtained  after  pooling  the  appropriate  eluted 
fractions.  The solid  lines show  the radioactivities in  the control rats,  and the  dotted lines show  those 
from  colchicine-treated  rats.  Each  point  represents  the  value  obtained  from  different  animals.  The 
30-  and  45-min  time-points  are  the  average  of  three  experiments,  and  the  others  are  from  single 
experiments. 
g  body weight) inhibits the synthesis of secretory 
and nonsecretory proteins (Table II) and causes a 
decrease  in  the  number  of  membrane-attached 
polysomes  and  an  increase  in  the  number  of 
smaller ribosomal units (monomers and dimers) in 
free  polysomes  (Table  I).  Electron  microscope 
examination of the colchicine-treated hepatocytes 
does  not  show  a  noticeable  degranulation  of the 
rough  ER but  does show  a  distension  of the  ER 
after this prolonged colchicine treatment. There is 
no other  obvious or gross  cytological damage  to 
the  cell,  although  a  greater  number  of secretory 
vesicles are seen in the colchicine-treated animals 
(Figs. 8A and 8B). 
DISCUSSION 
Within a  few minutes after intravenous adminis- 
tration to the rat, colchicine inhibits the secretion 
of  albumin  and  other  plasma  proteins  into  the 
blood, and its effect is long lasting. Inhibition of 
410  ThE  JOURNAL OF  CELL BIOLOGY " VOLUME 77, 1978 secretion  is  accompanied  by  a  retention  of  the 
nonsecreted  plasma  proteins  within  Golgi-de- 
rived  hepatic  secretory  vesicles,  and  previous 
kinetic  studies  show  that  colchicine  affects  the 
discharge, or exocytosis, of these secretory vesi- 
cles,  but does not affect earlier secretory events 
such as intracellular movement of nascent secre- 
tory proteins from  the  rough to the smooth  ER 
or  from  the  smooth  ER  to  the  Golgi apparatus 
(22).  Because  the  inhibitory effect of colchicine 
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FmURE  7  Time-course  of  incorporation  of  L-[4,5-3H]leucine  into  plasma  albumin  as  obtained  by 
DEAE-cellulose  chromatography.  Saline-  or  colchicine-treated  rats  were  injected  with  L-[4,5- 
aH]leueine  (as  in  Fig.  5),  and  at  various  time  intervals  blood  was  obtained  from  different  rats  by 
heart  puncture.  Radioactive  albumin  was  obtained  from  the  plasma  by  TCA-precipitation,  alcohol 
extraction,  and  DEAE-celluiose  chromatography as  described in Materials and  Methods.  At no  time 
was  there  any  evidence of any  radioactivity in proalbumin.  The  solid  lines show  the  radioactivity in 
plasma albumin of control rats and the dotted lines show that from colchicine-treated rats. 
FIGURE  8  Electron  micrographs  of  normal  and  colchicine-treated  rat  hepatocytes.  The  rats  were 
treated either with colchicine (25  /~mol/100 g  body  weight) (Fig.  8A) or with saline (Fig.  8B),  and 
the  livers  were  removed  after  3  h.  All  specimens  were  treated  as  described  in  Materials  and 
Methods.  Fig.  8A  shows a  large  field in the cytoplasm  of a  hepatocyte treated with colchicine. The 
ER  is  distended  and  secretory  vacuoles  and  peroxisomes  are  prominent.  Fig.  8B  shows  a  similar 
field from the saline-treated animals,  x  45,000. 
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the level of exocytosis of secretory vesicles, and 
because  one  of  the  final  processing  steps  in 
albumin synthesis and secretion in  vivo, also oc- 
curs in this cell fraction (11), we have studied in 
detail the effect of colchicine on the conversion 
of proaibumin to albumin, to gain a better under- 
standing of the  final steps in  albumin secretion 
and of the cellular mechanisms by which colchi- 
cine inhibits hepatic secretion. 
Albumin,  like  some  other  secretory  proteins 
(2), is probably first synthesized as a  larger pre- 
cursor protein with an octadecapeptide extension 
at the N-terminal end of proalbumin (29,  32),  is 
vectorially discharged into the lumen of the rough 
ER (25) where it exists as proalbumin (Fig. 5), and 
is transported stepwise to the smooth ER and to 
the  Golgi apparatus  (19).  When  the  Golgi-de- 
rived secretory vesicles are filled with secretory 
material and  are ready to be emptied from the 
cell, proalbumin  is converted  to  albumin.  It is 
interesting to note, however, that, although there 
is little or no conversion of proalbumin to albu- 
min  at  earlier  time-points  (20-30  min)  in  the 
less filled vesicles (Golgi fraction 3),  some con- 
version is noted at later time points. In the filled 
secretory vesicles represented by Golgi fractions 
1  and  2,  there  is  at  all  times  a  mixture  of 
proalbumin and  albumin (Figs. 5  and  6).  What 
mechanisms  activate the  removal of the N-ter- 
minal hexapeptide from  proalbumin in  filled ves- 
icles  (Golgi fractions  1  and  2)  but  not  in  less 
filled  Golgi  vesicles  (Golgi  fraction  3)  is  not 
known. Also not clear is whether this cleavage is 
a one-step procedure removing all six N-terminal 
amino  acids  at  once,  or  whether  intermediate 
steps  are  involved.  Our  experiments  measure 
only the known N-terminal amino acids of proal- 
bumin and serum albumin and thus do not allow 
the  measurement  of intermediate  steps.  There 
does appear to be  some  slight chromatographic 
difference between nascent albumin found in the 
Golgi and serum albumin (Fig. 5), but these two 
albumins have the following similar characteris- 
tics. They both precipitate with rabbit antiserum 
specific  to  rat  serum  albumin,  copurify  with 
ethanolic  extractions,  coelectrophorese  on  so- 
dium dodecyl sulfate (SDS)-urea polyacrylamide 
gels,  and  contain  the  same  N-terminal  amino 
acid, glutamic acid. This chromatographic differ- 
ence  observed  may  be  due  to  the  well-known 
ability of serum albumin to bind many substances 
in  the  blood.  Recently,  Peters  and  Reed  (18), 
using different separation techniques,  have also 
shown that, in addition to proalbumin, there may 
be  another form  of albumin in  the  hepatocyte, 
which,  although  structurally  similar  to  serum 
albumin,  behaves  differently  chromatographi- 
cally.  Thus,  it  is  quite  possible  that  another 
processing  step  in  the  conversion  of precursor 
albumin  to  serum  albumin  may  occur  in  the 
Golgi apparatus. 
Although  colchicine  inhibits  secretion  of 
plasma  proteins  into  the  blood  within  a  few 
minutes after administration (22),  a  distinct ac- 
cumulation of nonsecreted albumin in the Golgi 
cell fractions  is  not  noticed  until  after  20  min 
(Fig.  6)  of  administration,  because  coichicine 
does not impede the filling of these vesicles with 
nascent secretory proteins but only inhibits their 
discharge. This may explain why other workers, 
who  have  pulse-labeled with  radioactive  L-leu- 
cine  for  20  min,  after  lengthy  pretreatment  of 
rats  with  coichicine  (0.128  p~mol/100  g  body 
weight) have noticed inhibition of secretion into 
the blood but no accumulation of nascent albu- 
min within the Golgi cell fractions (11). 
That the effect of colchicine on albumin secre- 
tion described above occurs within minutes but 
the  inhibitory  effect  of  this  drug  on  protein 
synthesis is delayed and is not noticed until  1 h 
after  colchicine has  been  administered (Fig.  1) 
may suggest that the primary effect of colchicine 
in inhibiting secretion may influence other cellu- 
lar  mechanisms  which  may,  in  turn,  lead  to  a 
delayed inhibition of protein synthesis. It may be 
further expected that this feedback inhibition of 
protein  synthesis  may  be  specifically aimed  at 
slowing down  the  further synthesis of secretory 
plasma proteins which are prevented from being 
secreted by the action of colchicine. This, how- 
ever,  does  not  appear  to  be  the  case,  as  the 
delayed inhibition of protein synthesis by colchi- 
cine affects both membrane-attached polysomes, 
which are known to be active in the synthesis of 
secretory proteins (8, 9,  23,  30), and free poly- 
somes  (Fig.  4),  which  may  be  involved  in  the 
synthesis  of other  proteins.  Other  evidence  is 
that the synthesis of soluble cytoplasmic proteins, 
which may as a class represent nonsecreted pro- 
teins, and also the synthesis of a specific nonse- 
creted protein ferritin, were inhibited by colchi- 
cine to about the same extent as was the synthesis 
of the secretory plasma proteins (Table II). Thus, 
if inhibition of secretion by colchicine does cause 
a feedback inhibition of protein synthesis, it does 
414  ThE  JOURNAL OF CELL BIOLOGY" VOLUME 77, 1978 not  specifically  affect  the  synthesis  of  plasma 
proteins,  but  is a  more  general mechanism  also 
affecting other hepatic  proteins.  Another possi- 
bility  is  that  the  delayed  inhibition  of  protein 
synthesis by colchicine is not  tied  to  the  earlier 
inhibition  of  secretion  but  is  merely  due  to  a 
toxic effect of this drug. 
The  initial  effect  of  coichicine  in  inhibiting 
protein  secretion  is  a  widespread  phenomenon 
which  occurs  in  many  cells,  and  although  the 
mechanism of action is not yet well understood, 
it  is  usually  ascribed  to  the  antimicrotubular 
activity of this drug. Some possibilities to explain 
the accumulation  of secretory  vesicles in  response 
to  colchicine  are  that  discharge  of hepatic  secre- 
tory  vesicles  may  involve  microtubules  which 
may  directly  or  indirectly  act  to  move,  or  to 
place  these  vesicles  in  the  correct  juxtaposi- 
tion necessary to achieve contact and fusion with 
the plasma membrane at the blood front; or that 
colchicine  inhibits  exocytosis  by  some  other 
mechanisms which may or may not involve active 
participation of microtubules. The fact, however, 
that  colchicine  has  effects  on  the  hepatic  cell 
other than inhibition of secretion, and that these 
effects may  not  be  at  first  apparent  because  of 
delayed  mechanisms,  should  lead  to  caution  in 
interpreting  results  when  animals  or  cells  are 
treated  with colchicine for long periods of time. 
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